A Study of ZT002 in Healthy Participants

Clinical trial NCT05491421 · COMPLETED

Trial details

NCT number: NCT05491421
Sponsor: QL Biopharmaceutical Australia Pty Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2022-09-02
Primary completion: 2023-04-28
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.